National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005

Heart Lung Circ. 2005 Dec;14(4):275-91. doi: 10.1016/j.hlc.2005.10.010.
No abstract available

MeSH terms

  • Apolipoproteins / blood
  • Australia
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / prevention & control*
  • Cholesterol / blood
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Life Style
  • New Zealand
  • Practice Guidelines as Topic*
  • Risk Assessment
  • Triglycerides / blood

Substances

  • Apolipoproteins
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Triglycerides
  • Cholesterol